Similar articles

• Cholinesterase and carboxylesterase inhibition by dichlorvos and interactions with malathion and triorthotolyl phosphate.

  Cohen SD, Ehrich M. Cohen SD, et al. Toxicol Appl Pharmacol. 1976 Jul;37(1):39-48. doi: 10.1016/s0041-008x(76)80006-3. Toxicol Appl Pharmacol. 1976. PMID: 968905 No abstract available.
• Potentiation of acrylate ester toxicity by prior treatment with the carboxylesterase inhibitor triorthotolyl phosphate (TOTP).

  Silver EH, Murphy SD. Silver EH, et al. Toxicol Appl Pharmacol. 1981 Feb;57(2):208-19. doi: 10.1016/0041-008x(81)90281-7. Toxicol Appl Pharmacol. 1981. PMID: 7222037 No abstract available.
• Effect of dichlorvos (DDVP) on mouse liver glutathione levels and lack of potentiation by methyl iodide and TOTP.

  Ehrich M, Cohen SD. Ehrich M, et al. Biochem Pharmacol. 1977 May 15;26(10):997-1000. doi: 10.1016/0006-2952(77)90484-1. Biochem Pharmacol. 1977. PMID: 861048 No abstract available.
• Clinical significance of esterases in man.

  Williams FM. Williams FM. Clin Pharmacokinet. 1985 Sep-Oct;10(5):392-403. doi: 10.2165/00003088-198510050-00002. Clin Pharmacokinet. 1985. PMID: 3899454 Review.
• Delayed neurotoxicity and other consequences of organophosphate esters.

  Baron RL. Baron RL. Annu Rev Entomol. 1981;26:29-48. doi: 10.1146/annurev.en.26.010181.000333. Annu Rev Entomol. 1981. PMID: 7023372 Review. No abstract available.